Dr. Sherman`s research efforts over the past decade have evolved into several programs that are distinct in focus, yet coalesce into an overriding theme that include molecular genetic, biochemical and bioorganic chemical studies of microbial natural product biosynthesis. Metabolic engineering and combinatorial biosynthesis are powerful approaches for harnessing the tremendous metabolic capabilities of microorganisms, including primary and secondary pathways. New genomic-based technologies are considerably enhancing the ability to understand and manipulate complex biosynthetic systems and will enable vast new opportunities in medicine and industry. Dr. Sherman`s lab is exploring fundamental aspects of the systems molecular genetic analysis and combinatorial biosynthesis, as well as pursuing drug discovery opportunities in the area of infectious diseases and cancer.
